Vinnova funded project focussing on science and technology to translate ATMPs from lab to clinic. Includes bioprocess development, GMP production and logistics.
SWECARNET is Sweden’s network for clinical use of CAR T cells. Established in 2019 by the SDP5 Swelife-ATMP project of the same name.
For long-term transformation of the systems for successful development and implementation of ATMP.